JP2023530785A5 - - Google Patents

Info

Publication number
JP2023530785A5
JP2023530785A5 JP2023519156A JP2023519156A JP2023530785A5 JP 2023530785 A5 JP2023530785 A5 JP 2023530785A5 JP 2023519156 A JP2023519156 A JP 2023519156A JP 2023519156 A JP2023519156 A JP 2023519156A JP 2023530785 A5 JP2023530785 A5 JP 2023530785A5
Authority
JP
Japan
Prior art keywords
crystal
xrpd pattern
peaks
irradiation
degrees
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023519156A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023530785A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/036082 external-priority patent/WO2021252309A1/en
Publication of JP2023530785A publication Critical patent/JP2023530785A/ja
Publication of JP2023530785A5 publication Critical patent/JP2023530785A5/ja
Pending legal-status Critical Current

Links

JP2023519156A 2020-06-08 2021-06-07 {2-[3-シクロヘキシル-3-(trans-4-プロポキシ-シクロヘキシル)-ウレイド]-チアゾール-5-イルスルファニル}-酢酸の結晶形およびその使用 Pending JP2023530785A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063035994P 2020-06-08 2020-06-08
US63/035,994 2020-06-08
PCT/US2021/036082 WO2021252309A1 (en) 2020-06-08 2021-06-07 Crystalline forms of {2-[3-cyclohexyl-3-(trans-4-propoxy- cyclohexyl)-ureido]-thiazol-5-ylsulfanyl} -acetic acid and and uses thereof

Publications (2)

Publication Number Publication Date
JP2023530785A JP2023530785A (ja) 2023-07-19
JP2023530785A5 true JP2023530785A5 (https=) 2024-06-13

Family

ID=78846441

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023519156A Pending JP2023530785A (ja) 2020-06-08 2021-06-07 {2-[3-シクロヘキシル-3-(trans-4-プロポキシ-シクロヘキシル)-ウレイド]-チアゾール-5-イルスルファニル}-酢酸の結晶形およびその使用

Country Status (9)

Country Link
US (1) US20230219910A1 (https=)
EP (1) EP4161639A4 (https=)
JP (1) JP2023530785A (https=)
KR (1) KR20230048501A (https=)
CN (2) CN121202809A (https=)
AU (1) AU2021289591A1 (https=)
CA (1) CA3181665A1 (https=)
MX (2) MX2022015524A (https=)
WO (1) WO2021252309A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1213197A1 (zh) * 2013-03-04 2016-06-30 Vtv治疗有限责任公司 包括葡糖激酶活化劑的固體組合物及其製備和使用方法
CN112040945A (zh) 2018-06-12 2020-12-04 Vtv治疗有限责任公司 葡萄糖激酶激活剂与胰岛素或胰岛素类似物组合的治疗用途
US12391658B2 (en) 2020-02-18 2025-08-19 Vtv Therapeutics Llc Sulfoxide and sulfone glucokinase activators and methods of use thereof
CA3181722A1 (en) 2020-06-08 2021-12-16 Jing TENG Salts or co-crystals of {2-[3-cyclohexyl-3-(trans-4-propoxy-cyclohexyl)-ureido]-thiazol-5-ylsulfanyl}-acetic acid and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0506662B8 (pt) * 2004-01-06 2021-05-25 Novo Nordisk As compostos ativadores de glucoquinase
NZ603614A (en) * 2010-05-26 2014-10-31 Transtech Pharma Llc Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator
BR112014028622A2 (pt) * 2012-05-17 2017-06-27 Transtech Pharma Llc composições de ativador de glucoquinase para o tratamento de diabetes
HK1213197A1 (zh) * 2013-03-04 2016-06-30 Vtv治疗有限责任公司 包括葡糖激酶活化劑的固體組合物及其製備和使用方法
CN105050585A (zh) * 2013-03-04 2015-11-11 Vtv治疗有限责任公司 稳定的葡萄糖激酶活化剂组合物
EP3556354B1 (en) * 2016-12-15 2025-05-21 Hua Medicine (Shanghai) Ltd. Oral preparation of glucokinase activator and preparation method therefor

Similar Documents

Publication Publication Date Title
JP2023530785A5 (https=)
JP2021119136A5 (https=)
JPWO2022138988A5 (https=)
JP2025176008A5 (https=)
JP2023530786A5 (https=)
JP2023519891A5 (https=)
JP2016528179A5 (https=)
CN115461344B (zh) 一种glp-1受体激动剂的晶型a及其制备方法
RU2006126977A (ru) Кристаллическая форма соли 4-(3-хлор-4-(циклопропиламинокарбонил)аминофенокси)-7-метокси-6-хинолинкарбоксамида или сольвата этой соли и способы ее получения
WO2003037881A1 (en) α-FORM OR ß-FORM CRYSTAL OF ACETANILIDE DERIVATIVE
JP2009544696A (ja) バニロイド受容体アンタゴニストとしての、新規化合物、その異性体またはその薬学的に許容される塩;並びにそれを含む医薬組成物
JP2010524966A5 (https=)
JP2013506670A5 (https=)
JP2023083528A5 (https=)
JP2025522923A (ja) Glp-1rアゴニストの塩並びにその製造方法及び応用
WO2010069124A1 (zh) 酰胺基噻唑衍生物及其制备方法和用途
JP2025148397A5 (https=)
JP2009534373A5 (https=)
JP2024095561A5 (https=)
JP2011515421A5 (https=)
JP2005529084A5 (https=)
RU2004127585A (ru) Кристаллическая натриевая соль парекоксиба
JP6473820B2 (ja) 塩酸ヨンケナフィルの多形体及びその調製方法、組成物並びに用途
JP2022540678A5 (https=)
JP6275644B2 (ja) N−[2−({2−[(2S)−2−シアノピロリジン−1−イル]−2−オキソエチル}アミノ)−2−メチルプロピル]−2−メチルピラゾロ[1,5−a]ピリミジン−6−カルボキサミドの結晶